Literature DB >> 6630574

Use of gas-liquid chromatography as a screening test for toxigenic Clostridium difficile in diarrhoeal stools.

F Pepersack, M Labbe, C Nonhoff, E Schoutens.   

Abstract

In order to determine if gas-liquid chromatography (GLC) on concentrated stool extracts could be substituted to cell culture assay for cytotoxicity, we prospectively studied 154 diarrhoeal stools submitted for detection of Clostridium difficile toxin. Isocaproic-positive samples were cultured on egg yolk agar supplemented with cycloserine, cefoxitin and fructose for isolation of C difficile, and on egg yolk agar plus kanamycin for isolation of other clostridium species. Of the 154 samples, 129 were GLC-negative (height of the isocaproic peak less than 1.2 cm) and were toxin-negative. Twenty-five stools yielded isocaproic acid; C difficile isolated from 13 of them, six of which were also toxin-positive. Four other isocaproic-positive samples yielded C bifermentans and C sordellii; all were toxin-negative. These results indicate that a negative GLC is an excellent screening test for excluding C difficile infection; positive results must be checked by toxin testing and culture since they are not necessarily associated with the presence of C difficile or its toxin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630574      PMCID: PMC498537          DOI: 10.1136/jcp.36.11.1233

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Gas-liquid chromatography and Clostridium difficile.

Authors:  S P Borriello
Journal:  Lancet       Date:  1981-12-05       Impact factor: 79.321

2.  Partial preservation of pancreatic beta-cell function in children with diabetes.

Authors:  R B Elliott; J R Crossley; C C Berryman; A G James
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

3.  Rapid detection of Clostridium difficile toxin in human feces.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

4.  A micro-method for detecting toxins in pseudomembranous colitis.

Authors:  R H George
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

5.  Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution.

Authors:  I R Poxton; M D Byrne
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

6.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Modified Lombard-Dowell broth as a general growth medium.

Authors:  M T Jessee; P J Robinson
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

Review 8.  Diarrhea and colitis associated with antimicrobial therapy in man and animals.

Authors:  W L George; R D Rolfe; V L Sutter; S M Finegold
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

9.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

10.  Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease.

Authors:  J T LaMont; Y M Trnka
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

View more
  10 in total

1.  Incidence and significance of Clostridium difficile in hospitalized cancer patients.

Authors:  M Gérard; N Defresne; D Daneau; P Van der Auwera; M Delmée; A M Bourguignon; F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 2.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Presumptive identification of Clostridium difficile by detection of p-cresol in prepared peptone yeast glucose broth supplemented with p-hydroxyphenylacetic acid.

Authors:  G Sivsammye; H V Sims
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Evaluation of gas-liquid chromatography for the rapid diagnosis of Clostridium difficile associated disease.

Authors:  P Gianfrilli; A Pantosti; I Luzzi
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

Review 5.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Selective enrichment broth culture for detection of Clostridium difficile and associated cytotoxin.

Authors:  A G Buchanan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

Review 8.  Laboratory diagnosis of Clostridium difficile-associated diarrhoea.

Authors:  R A Bowman; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

9.  Identification of Clostridium difficile in stool specimens by culture-enhanced gas-liquid chromatography.

Authors:  L L Johnson; L V McFarland; P Dearing; V Raisys; F D Schoenknecht
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

10.  Faecal volatile biomarkers of Clostridium difficile infection.

Authors:  Mitesh Patel; Dawn Fowler; Jeremy Sizer; Christopher Walton
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.